Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT) – findings from the GerHIT multi-centre registry study-Reference-Cited by-同舟云学术

Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT) – findings from the GerHIT multi-centre registry study

Published:2014-07 Issue:1 Volume:134 Page:29-35
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Schindewolf Marc,Steindl Julia,Beyer-Westendorf Jan,Schellong Sebastian,Dohmen Pascal Maria,Brachmann Johannes,Madlener Katharina,Pötzsch Bernd,Klamroth Robert,Hankowitz Johannes,Banik Norbert,Eberle Sonja,Kropff Stefan,Müller Markus Michael,Lindhoff-Last Edelgard

Publisher

Elsevier BV

Subject

Hematology

Reference39 articles.

1. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis recognize different epitopes on heparin: platelet factor 4;Suh;Blood,1998

2. Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4;Kelton;Blood,1994

3. Heparin-induced thrombocytopenia: mechanism of interaction of the heparin-dependent antibody with platelets;Chong;Br J Haematol,1989

4. Heparin-induced skin lesions;Schindewolf;Lancet,2012

5. Heparin-induced skin lesions: rarely associated with heparin-induced thrombocytopenia;Schindewolf;J Thromb Haemost,2010

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autoimmune Heparin-Induced Thrombocytopenia;Journal of Clinical Medicine;2023-11-03

2. Fondaparinux Sodium: Recent Advances in the Management of Thrombosis;Journal of Cardiovascular Pharmacology and Therapeutics;2023-01-01

3. Prevention, Diagnostics and Treatment of Deep Vein Thrombosis. Russian Experts Consensus;Flebologiia;2023

4. Cost-effectiveness analysis of alternative anticoagulation in suspected heparin-induced thrombocytopenia;BLOOD ADV;2022

5. Cost-effectiveness analysis of alternative anticoagulation in suspected heparin-induced thrombocytopenia;Blood Advances;2022-05-20